These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 7518514

  • 21. Persistent nicotinic blockade by chlorisondamine of noradrenergic neurons in rat brain and cultured PC12 cells.
    Reuben M, Louis M, Clarke PB.
    Br J Pharmacol; 1998 Nov; 125(6):1218-27. PubMed ID: 9863650
    [Abstract] [Full Text] [Related]

  • 22. (S)-(-)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H]dopamine release from rat striatal slices in a calcium-dependent manner.
    Dwoskin LP, Teng L, Buxton ST, Crooks PA.
    J Pharmacol Exp Ther; 1999 Mar; 288(3):905-11. PubMed ID: 10027825
    [Abstract] [Full Text] [Related]

  • 23. Effects of a novel cholinergic ion channel agonist SIB-1765F on locomotor activity in rats.
    Menzaghi F, Whelan KT, Risbrough VB, Rao TS, Lloyd GK.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):384-92. PubMed ID: 8996219
    [Abstract] [Full Text] [Related]

  • 24. C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists.
    Abin-Carriquiry JA, Voutilainen MH, Barik J, Cassels BK, Iturriaga-Vásquez P, Bermudez I, Durand C, Dajas F, Wonnacott S.
    Eur J Pharmacol; 2006 Apr 24; 536(1-2):1-11. PubMed ID: 16563372
    [Abstract] [Full Text] [Related]

  • 25. Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains.
    Warpman U, Nordberg A.
    Neuroreport; 1995 Nov 27; 6(17):2419-23. PubMed ID: 8747166
    [Abstract] [Full Text] [Related]

  • 26. Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes.
    Marks MJ, Farnham DA, Grady SR, Collins AC.
    J Pharmacol Exp Ther; 1993 Feb 27; 264(2):542-52. PubMed ID: 8437106
    [Abstract] [Full Text] [Related]

  • 27. Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors.
    Decker MW, Anderson DJ, Brioni JD, Donnelly-Roberts DL, Kang CH, O'Neill AB, Piattoni-Kaplan M, Swanson S, Sullivan JP.
    Eur J Pharmacol; 1995 Jun 23; 280(1):79-89. PubMed ID: 7498257
    [Abstract] [Full Text] [Related]

  • 28. N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slices.
    Grinevich VP, Crooks PA, Sumithran SP, Haubner AJ, Ayers JT, Dwoskin LP.
    J Pharmacol Exp Ther; 2003 Sep 23; 306(3):1011-20. PubMed ID: 12766255
    [Abstract] [Full Text] [Related]

  • 29. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
    Clarke PB, Reuben M.
    Br J Pharmacol; 1996 Feb 23; 117(4):595-606. PubMed ID: 8646402
    [Abstract] [Full Text] [Related]

  • 30. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.
    Bontempi B, Whelan KT, Risbrough VB, Lloyd GK, Menzaghi F.
    Neuropsychopharmacology; 2003 Jul 23; 28(7):1235-46. PubMed ID: 12700710
    [Abstract] [Full Text] [Related]

  • 31. [3H]cytisine binding to nicotinic cholinergic receptors in brain.
    Pabreza LA, Dhawan S, Kellar KJ.
    Mol Pharmacol; 1991 Jan 23; 39(1):9-12. PubMed ID: 1987453
    [Abstract] [Full Text] [Related]

  • 32. Novel isoxazoles which interact with brain cholinergic channel receptors have intrinsic cognitive enhancing and anxiolytic activities.
    Garvey DS, Wasicak JT, Decker MW, Brioni JD, Buckley MJ, Sullivan JP, Carrera GM, Holladay MW, Arneric SP, Williams M.
    J Med Chem; 1994 Apr 15; 37(8):1055-9. PubMed ID: 7909335
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacological characterization of SIB-1663, a conformationally rigid analog of nicotine.
    Rao TS, Sacaan AI, Menzaghi FM, Reid RT, Adams PB, Correa LD, Whelan KT, Vernier JM.
    Brain Res; 2004 Apr 02; 1003(1-2):42-53. PubMed ID: 15019562
    [Abstract] [Full Text] [Related]

  • 34. Nicotinic-receptor mediation of S(-)nornicotine-evoked -3H-overflow from rat striatal slices preloaded with -3H-dopamine.
    Teng L, Crooks PA, Buxton ST, Dwoskin LP.
    J Pharmacol Exp Ther; 1997 Nov 02; 283(2):778-87. PubMed ID: 9353398
    [Abstract] [Full Text] [Related]

  • 35. The "calcium antagonist" TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester] is a potent, non-competitive, functional antagonist at diverse nicotinic acetylcholine receptor subtypes.
    Bencherif M, Eisenhour CM, Prince RJ, Lippiello PM, Lukas RJ.
    J Pharmacol Exp Ther; 1995 Dec 02; 275(3):1418-26. PubMed ID: 8531111
    [Abstract] [Full Text] [Related]

  • 36. Synthesis and nicotinic activity of epiboxidine: an isoxazole analogue of epibatidine.
    Badio B, Garraffo HM, Plummer CV, Padgett WL, Daly JW.
    Eur J Pharmacol; 1997 Feb 26; 321(2):189-94. PubMed ID: 9063687
    [Abstract] [Full Text] [Related]

  • 37. The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter release.
    Dajas-Bailador FA, Heimala K, Wonnacott S.
    Mol Pharmacol; 2003 Nov 26; 64(5):1217-26. PubMed ID: 14573772
    [Abstract] [Full Text] [Related]

  • 38. Cardiovascular and behavioral responses to nicotinic agents administered intrathecally.
    Khan IM, Taylor P, Yaksh TL.
    J Pharmacol Exp Ther; 1994 Jul 26; 270(1):150-8. PubMed ID: 8035311
    [Abstract] [Full Text] [Related]

  • 39. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes.
    Alkondon M, Albuquerque EX.
    J Pharmacol Exp Ther; 1993 Jun 26; 265(3):1455-73. PubMed ID: 8510022
    [Abstract] [Full Text] [Related]

  • 40. In vitro evaluation of 11C-labeled (S)-nicotine, (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole, and (R,S)-1-methyl-2-(3-pyridyl)azetidine as nicotinic receptor ligands for positron emission tomography studies.
    Sihver W, Fasth KJ, Ogren M, Bivehed H, Bergström M, Nordberg A, Watanabe Y, Långström B.
    J Neurochem; 1998 Oct 26; 71(4):1750-60. PubMed ID: 9751211
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.